442 related articles for article (PubMed ID: 7929268)
1. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park JE; Chen HH; Winer J; Houck KA; Ferrara N
J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
[TBL] [Abstract][Full Text] [Related]
2. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
3. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
Landgren E; Schiller P; Cao Y; Claesson-Welsh L
Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
[TBL] [Abstract][Full Text] [Related]
4. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.
Shore VH; Wang TH; Wang CL; Torry RJ; Caudle MR; Torry DS
Placenta; 1997 Nov; 18(8):657-65. PubMed ID: 9364601
[TBL] [Abstract][Full Text] [Related]
8. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
10. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
Clauss M; Weich H; Breier G; Knies U; Röckl W; Waltenberger J; Risau W
J Biol Chem; 1996 Jul; 271(30):17629-34. PubMed ID: 8663424
[TBL] [Abstract][Full Text] [Related]
11. Computer modelling of the receptor-binding domains of VEGF and PIGF.
Walsh TP; Grant GH
Protein Eng; 1997 Apr; 10(4):389-98. PubMed ID: 9194163
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells.
Barleon B; Hauser S; Schöllmann C; Weindel K; Marmé D; Yayon A; Weich HA
J Cell Biochem; 1994 Jan; 54(1):56-66. PubMed ID: 8126087
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the VEGF binding site on the Flt-1 receptor.
Herley MT; Yu Y; Whitney RG; Sato JD
Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
[TBL] [Abstract][Full Text] [Related]
14. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
[TBL] [Abstract][Full Text] [Related]
15. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.
Kaplan JB; Sridharan L; Zaccardi JA; Dougher-Vermazen M; Terman BI
Growth Factors; 1997; 14(4):243-56. PubMed ID: 9386989
[TBL] [Abstract][Full Text] [Related]
17. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
[TBL] [Abstract][Full Text] [Related]
19. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
20. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
